Evidity Health Capital is a late-stage venture capital and growth equity firm that focuses on the healthcare sector, specifically targeting medical devices, in vitro diagnostics, and disruptive digital health. The firm invests in private companies with commercialized products that require growth capital to reach profitability. Evidity Health Capital typically participates in Series A through Series D funding rounds, providing the necessary resources to scale innovative healthcare solutions.

Notable portfolio companies include Augmedics, EndoGastric Solutions, Magnolia Medical Technologies, Sonde Health, and Tryton Medical. The firm is led by a cohesive team of three investment partners who bring diverse and complementary expertise to the table. Evidity Health Capital prides itself on being value-focused and evidence-based, offering business-building support to its portfolio companies. This hands-on approach helps ensure that the companies they invest in can achieve sustainable growth and success in the competitive healthcare market.